Godavari Drugs Ltd shares jump 6.12% as board approves MOA amendment.
Why did Godavari Drugs Ltd shares jump today?
Godavari Drugs Ltd shares saw significant positive movement today, rising 6.12% to close at ₹106.01. This notable jump occurred as of Friday at 05:56 PM, indicating strong investor interest following the company's latest announcement.
The primary driver for this surge was the outcome of a Board of Directors meeting held on August 31, 2026. The board officially approved a key amendment to the company's Memorandum of Association (MOA). Specifically, they sanctioned the insertion of a new main object clause that would allow the company to enter the business of nutraceuticals, dietary supplements, natural extracts, and food ingredients. This proposed change signals a potential strategic expansion into the growing health and wellness sector.
This alteration is now subject to the necessary regulatory approvals from the Ministry of Corporate Affairs and, crucially, the approval of the company's shareholders. The matter will be put to a vote during the upcoming 38th Annual General Meeting scheduled for September 25, 2026. The market's reaction suggests optimism about the company's plans to diversify its business portfolio.
What does Godavari Drugs Ltd do?
Godavari Drugs Limited is a company registered in Secunderabad, Telangana, India. It operates as a business entity with established contact channels including a website and telephone lines.
The company is expanding its business scope into the nutraceuticals and food ingredient sector. Its Board of Directors has approved adding new main objects to its memorandum of association specifically for nutraceuticals, dietary supplements, natural extracts, and food ingredients. This expansion is subject to member approval at the upcoming 38th Annual General Meeting.
Godavari Drugs Ltd Financials
In CroresBetween December 2025 and March 2026, Godavari Drugs Ltd demonstrated clear financial growth. Revenue rose from ₹22.18 crores to ₹33.16 crores, representing an increase of approximately 49.5%. Correspondingly, profit also expanded during the same period, growing from ₹0.76 crores to ₹1.29 crores, a rise of about 70%. The data indicates a positive upward trend in both top-line revenue and bottom-line profit for the company over these two quarters.
Godavari Drugs Ltd Shareholding Pattern
Promoter holding stands at 40.23% of the total share capital. Foreign Institutional Investors (FIIs) hold 0.0% stake in the company, while Domestic Institutional Investors (DIIs) hold 2.74%. Public shareholders hold the remaining 57.04% stake in Godavari Drugs Ltd.
Godavari Drugs Ltd FAQs
Q: Why did Godavari shares jump 6.12% today?
Amendment to MOA of the company was approved by Board of Directors. The Proposed change in MOA of the company is subject to necessary approvals from Ministry of Corporate Affairs, Shareholders ..... This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Godavari Drugs Ltd?
As per the latest data, promoters hold 40.23% stake in Godavari Drugs Ltd, while FII holding stands at 0.0%. Domestic institutional investors hold 2.74%, and public shareholders account for 57.04% of the equity.
Q: What is the current stock price of Godavari Drugs Ltd?
Godavari Drugs Ltd shares are currently trading at ₹106.01, recording a gain of 6.12% from the previous close.
Q: What is the market capitalization of Godavari Drugs Ltd?
The company currently has a market capitalization of ₹115.7 crore, reflecting its valuation in the Indian equity market.